Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T16:23:36.381Z.
Calculation as of: 2026-10-06T16:23:36.381Z.
Quote observation: 2026-10-06T16:19:45.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47811cd6fce140e68777d2609bf88a35ade871fb75fdb0cf4ca3c33c868081b2
PEG RATIO
N/A
Medicus Pharma Ltd. Common Stock
Market Cap
$10.05M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.05M | N/A |
| Lifeward Ltd. (LFWD)vs › | $9.92M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.72M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.89M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.47M | N/A |
| MetaVia Inc. (MTVA)vs › | $10.08M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.64M | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.68M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
